myasthenia gravis
Rystiggo Approved for gMG in Adults Who Are AChR/MuSK Antibody–Positive
The approval was based on safety and efficacy data from the MycarinG study of Rystiggo in adult patients with gMG.
JUNE 27, 2023
FDA Approves Vyvgart for Myasthenia Gravis
Efgartigimod alfa-fcab, the first in a new class of medication, is an antibody fragment that binds to the FcRn, ...
DECEMBER 20, 2021
Load more